ERVW-1 and breast carcinoma: Furthermore, monoclonal antibodies against HERV-K Env protein, which can inhibit growth and induce apoptosis of breast cancer cells, significantly reduced growth of xenograft tumors in mice, showing potential as novel immunotherapeutic agents for breast cancer therapy (Wang-Johanning et al., 2012).